Logo image of HCAI

HUACHEN AI PARKING MANAGEMEN (HCAI) Stock Fundamental Analysis

NASDAQ:HCAI - Nasdaq - KYG4645R1149 - Common Stock - Currency: USD

1.35  -0.02 (-1.46%)

After market: 1.34 -0.01 (-0.74%)

Fundamental Rating

4

Overall HCAI gets a fundamental rating of 4 out of 10. We evaluated HCAI against 128 industry peers in the Machinery industry. HCAI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HCAI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year HCAI was profitable.
HCAI had a positive operating cash flow in the past year.
HCAI Yearly Net Income VS EBIT VS OCF VS FCFHCAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.05%, HCAI is in the better half of the industry, outperforming 71.09% of the companies in the same industry.
With an excellent Return On Equity value of 23.34%, HCAI belongs to the best of the industry, outperforming 88.28% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.71%, HCAI belongs to the top of the industry, outperforming 82.03% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HCAI is in line with the industry average of 10.67%.
The 3 year average ROIC (10.36%) for HCAI is below the current ROIC(13.71%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.05%
ROE 23.34%
ROIC 13.71%
ROA(3y)5.15%
ROA(5y)N/A
ROE(3y)16.83%
ROE(5y)N/A
ROIC(3y)10.36%
ROIC(5y)N/A
HCAI Yearly ROA, ROE, ROICHCAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20

1.3 Margins

HCAI has a Profit Margin (5.21%) which is comparable to the rest of the industry.
HCAI has a Operating Margin (6.88%) which is in line with its industry peers.
HCAI has a worse Gross Margin (13.46%) than 84.38% of its industry peers.
In the last couple of years the Gross Margin of HCAI has declined.
Industry RankSector Rank
OM 6.88%
PM (TTM) 5.21%
GM 13.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.75%
GM growth 5YN/A
HCAI Yearly Profit, Operating, Gross MarginsHCAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30 40

7

2. Health

2.1 Basic Checks

HCAI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for HCAI has been reduced compared to 1 year ago.
Compared to 1 year ago, HCAI has an improved debt to assets ratio.
HCAI Yearly Shares OutstandingHCAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
HCAI Yearly Total Debt VS Total AssetsHCAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 3.90 indicates that HCAI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.90, HCAI is in the better half of the industry, outperforming 64.84% of the companies in the same industry.
HCAI has a debt to FCF ratio of 7.68. This is a slightly negative value and a sign of low solvency as HCAI would need 7.68 years to pay back of all of its debts.
HCAI has a Debt to FCF ratio (7.68) which is in line with its industry peers.
HCAI has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
HCAI's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. HCAI outperforms 72.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Altman-Z 3.9
ROIC/WACC1.61
WACC8.54%
HCAI Yearly LT Debt VS Equity VS FCFHCAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.58 indicates that HCAI has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.58, HCAI is doing good in the industry, outperforming 69.53% of the companies in the same industry.
A Quick Ratio of 2.47 indicates that HCAI has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.47, HCAI belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.47
HCAI Yearly Current Assets VS Current LiabilitesHCAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

4

3. Growth

3.1 Past

HCAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.87%, which is quite impressive.
HCAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 58.19%.
The Revenue has been growing by 69.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)41.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.67%
Revenue 1Y (TTM)58.19%
Revenue growth 3Y69.18%
Revenue growth 5YN/A
Sales Q2Q%19.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HCAI Yearly Revenue VS EstimatesHCAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.25, the valuation of HCAI can be described as very reasonable.
Based on the Price/Earnings ratio, HCAI is valued cheaply inside the industry as 89.06% of the companies are valued more expensively.
HCAI is valuated cheaply when we compare the Price/Earnings ratio to 26.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.25
Fwd PE N/A
HCAI Price Earnings VS Forward Price EarningsHCAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HCAI is valued a bit cheaper than 71.88% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HCAI indicates a slightly more expensive valuation: HCAI is more expensive than 60.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.27
EV/EBITDA 10.14
HCAI Per share dataHCAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HCAI!.
Industry RankSector Rank
Dividend Yield N/A

HUACHEN AI PARKING MANAGEMEN

NASDAQ:HCAI (6/6/2025, 8:00:01 PM)

After market: 1.34 -0.01 (-0.74%)

1.35

-0.02 (-1.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap45.54M
AnalystsN/A
Price TargetN/A
Short Float %0.33%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.25
Fwd PE N/A
P/S 0.64
P/FCF 30.27
P/OCF 30.23
P/B 2.88
P/tB 2.88
EV/EBITDA 10.14
EPS(TTM)0.12
EY8.89%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY3.3%
OCF(TTM)0.04
OCFY3.31%
SpS2.1
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.05%
ROE 23.34%
ROCE 15.04%
ROIC 13.71%
ROICexc 13.73%
ROICexgc 13.73%
OM 6.88%
PM (TTM) 5.21%
GM 13.46%
FCFM 2.12%
ROA(3y)5.15%
ROA(5y)N/A
ROE(3y)16.83%
ROE(5y)N/A
ROIC(3y)10.36%
ROIC(5y)N/A
ROICexc(3y)10.5%
ROICexc(5y)N/A
ROICexgc(3y)10.51%
ROICexgc(5y)N/A
ROCE(3y)11.67%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.75%
GM growth 5YN/A
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Debt/EBITDA 0.51
Cap/Depr 0.27%
Cap/Sales 0%
Interest Coverage 7.99
Cash Conversion 26.45%
Profit Quality 40.75%
Current Ratio 2.58
Quick Ratio 2.47
Altman-Z 3.9
F-Score6
WACC8.54%
ROIC/WACC1.61
Cap/Depr(3y)68.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)58.19%
Revenue growth 3Y69.18%
Revenue growth 5YN/A
Sales Q2Q%19.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y144.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y161.09%
OCF growth 3Y-18.85%
OCF growth 5YN/A